Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,715.00
+12.00 (0.70%)
Jan 29, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 95.23 billion as of January 29, 2026. Its market cap has decreased by -55.05% in one year.
Market Cap
95.23B
Enterprise Value
194.47B
Revenue
87.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,715.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 95.23B, a decrease of -59.85%. That is a compound annual growth rate of -7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 95.23B | -3.76% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 214.91B |
| EASY BIO,Inc. | 210.40B |
| Genexine | 208.98B |
| Macrogen | 176.50B |
| ENCell | 171.54B |
| GeneOne Life Science | 157.37B |
| IMB Dx | 130.37B |
| Oncocross | 110.90B |